Collaboration between MIP Technologies AB and sanofi-aventis has been announced, with the aim of developing molecularly imprinted polymers (MIPs) for the analysis of pharmacologically active peptides from plasma samples.
Collaboration between MIP Technologies AB and sanofi-aventis has been announced, with the aim of developing molecularly imprinted polymers (MIPs) for the analysis of pharmacologically active peptides from plasma samples. The use of MIPs for selective recognition of peptides and proteins is an area that the companies hope will open up the technology to numerous applications in the diagnostic, pharmaceutical and biopharmaceutical industries.
"We are looking to move into the development of peptide-selective MIPs, which represents a valuable piece of the separations market," comments Dr Anthony Rees, CEO at MIP Technologies. "The benefit of being able to address a large, new global market for molecularly imprinted polymers represents a significant commercial opportunity."
Sanofi-aventis will have exclusive use of the polymer in the analysis of proprietary peptide candidates, while MIP Technologies will retain the rights to use the polymers for other applications. The companies also claim that the MIP material developed during the collaboration may be suitable for selective peptide purification at preparative or process scale.
For more information about this partnership please visit MIP Technologies, website at www.miptechnologies.com
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.